Comparison of Image Quality and Diagnostic Performance of Cone-Beam CT during Drug-Eluting Embolic Transarterial Chemoembolization and Multidetector CT in the Detection of Hepatocellular Carcinoma

Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure

“…Moreover, authors report the ability of monophasic CBCT to depict more hyper-vascular foci (HVF) defined as occult nodules in respect to pre-procedural second-line imaging modalities (SLIM), (rate: 11.5-28.7%) [15,16]. The rationale to compare the diagnostic performance of DP-CBCT vs SLIM is based on several hypotheses.…”

“…The rationale to compare the diagnostic performance of DP-CBCT vs SLIM is based on several hypotheses. Firstly, CBCT has higher contrast-to-noise ratio and spatial resolution respect to MDCT [15,17].…”

Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards

“…All adverse events (AEs) were recorded and graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events, Version 4.03 (15). Postembolization syndrome (PES) was defined as the onset of fever and/or nausea and/or pain after the procedure and a visual analog scale score > 6 evaluated before discharge.…”

Arms Down Cone Beam CT Hepatic Angiography: Are We Focusing on the Wrong Target?

“…However, literature shows that the major pivotal strength of CBCT, either mono-phasic or possibly bi-phasic, is the ability to depict in intra-procedurally ''occult lesions'', not visible at pre-procedural second-line non-invasive imaging (MRI, MDCT) [3]. This ability is not just for show, but yield to some major clinical implications: the visualization of an occult nodule identifies a subset of population experiencing fast tumour growth, having consequences on the number of adjunctive treatments controlling tumour growth (adjunctive RFA, or TACE procedures) and prioritization for transplantation [4].…”